Eidostx
1 known investors
Eidos Therapeutics is a biopharmaceutical company focused on transthyretin amyloid cardiomyopathy (ATTR-CM), a rare heart disease caused by destabilization of the transthyretin (TTR) protein. Its website provides disease information and practice resources for health care professionals.
Investors Β· 1
Frequently asked questions
- What does Eidostx do?
- Eidos Therapeutics is a biopharmaceutical company focused on transthyretin amyloid cardiomyopathy (ATTR-CM), a rare heart disease caused by destabilization of the transthyretin (TTR) protein. Its website provides disease information and practice resources for health care professionals.
- Who are Eidostx's investors?
- Eidostx's investors include Aisling Capital.